Stockreport

BioAtla Announces Formal Process to Evaluate Strategic Options to Monetize Assets [Yahoo! Finance]

BioAtla, Inc.  (BCAB) 
PDF company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, announced that the Board of Directors [Read more]